Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials
Adili Tuersun, Guanxin Hou, Gang Cheng
Topics & Concepts
MedicinePancreatitisObservational studyMeta-analysisRandomized controlled trialPancreatic cancerDipeptidyl peptidase-4Type 2 diabetesInternal medicineDipeptidyl peptidase-4 inhibitorDiabetes mellitusSitagliptinCancerOncologyEndocrinologyDiabetes Treatment and ManagementPancreatic and Hepatic Oncology ResearchPeptidase Inhibition and Analysis